Cite
ADAMTS13 activity may predict the cumulative survival of patients with liver cirrhosis in comparison with the Child-Turcotte-Pugh score and the Model for End-Stage Liver Disease score.
MLA
Takaya, Hiroaki, et al. “ADAMTS13 Activity May Predict the Cumulative Survival of Patients with Liver Cirrhosis in Comparison with the Child-Turcotte-Pugh Score and the Model for End-Stage Liver Disease Score.” Hepatology Research, vol. 42, no. 5, May 2012, pp. 459–72. EBSCOhost, https://doi.org/10.1111/j.1872-034X.2011.00950.x.
APA
Takaya, H., Uemura, M., Fujimura, Y., Matsumoto, M., Matsuyama, T., Kato, S., Morioka, C., Ishizashi, H., Hori, Y., Fujimoto, M., Tsujimoto, T., Kawaratani, H., Toyohara, M., Kurumatani, N., & Fukui, H. (2012). ADAMTS13 activity may predict the cumulative survival of patients with liver cirrhosis in comparison with the Child-Turcotte-Pugh score and the Model for End-Stage Liver Disease score. Hepatology Research, 42(5), 459–472. https://doi.org/10.1111/j.1872-034X.2011.00950.x
Chicago
Takaya, Hiroaki, Masahito Uemura, Yoshihiro Fujimura, Masanori Matsumoto, Tomomi Matsuyama, Seiji Kato, Chie Morioka, et al. 2012. “ADAMTS13 Activity May Predict the Cumulative Survival of Patients with Liver Cirrhosis in Comparison with the Child-Turcotte-Pugh Score and the Model for End-Stage Liver Disease Score.” Hepatology Research 42 (5): 459–72. doi:10.1111/j.1872-034X.2011.00950.x.